Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neonatology
  Free Subscription

Articles published in
Lancet
    February 2026
  1. THE EDITORS OF THE LANCET
    Expression of Concern: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.
    Lancet. 2026 Feb 3:S0140-6736(26)00245-X. doi: 10.1016/S0140-6736(26)00245.
    >> Share

    January 2026
  2. KIMATHI D, Juan-Giner A, Bob NS, Orindi B, et al
    Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
    Lancet. 2026 Jan 13:S0140-6736(25)02069-0. doi: 10.1016/S0140-6736(25)02069.
    >> Share

  3. TURTLE L
    Yellow fever vaccine minimum fractional dosing does not extend to infants.
    Lancet. 2026 Jan 13:S0140-6736(25)02364-5. doi: 10.1016/S0140-6736(25)02364.
    >> Share

  4. YANG YT
    A risky rollback on hepatitis B birth dose in the USA.
    Lancet. 2026 Jan 9:S0140-6736(25)02630-3. doi: 10.1016/S0140-6736(25)02630.
    >> Share

    December 2025
  5. ZAIGHAM M, Visser GHA, Galadanci H
    Announcing the Lancet Commission on Maternal and Newborn Health.
    Lancet. 2025 Dec 23:S0140-6736(25)02599-1. doi: 10.1016/S0140-6736(25)02599.
    >> Share

  6. GENC K
    Turkiye rocked by newborn care scandal.
    Lancet. 2025;404:2503-2504.
    >> Share

  7. VAKANIAKI EH, Barhishindi I, Mubiala A, Malembaka EB, et al
    Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study.
    Lancet. 2025 Dec 19:S0140-6736(25)02309-8. doi: 10.1016/S0140-6736(25)02309.
    >> Share

  8. GOADSBY J, Syngelaki A, Magee LA, von Dadelszen P, et al
    Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial.
    Lancet. 2025 Dec 4:S0140-6736(25)01207-3. doi: 10.1016/S0140-6736(25)01207.
    >> Share

    November 2025
  9. GUPTA S, Darmstadt GL, Kirkwood B, Ashorn P, et al
    A clinical practice guide to transform care and save newborn lives with kangaroo mother care.
    Lancet. 2025 Nov 14:S0140-6736(25)02173-7. doi: 10.1016/S0140-6736(25)02173.
    >> Share

    October 2025
  10. ABDOOL KARIM Q, Mohan J, Bhutta ZA
    Advancing women, maternal, newborn, and child health equity.
    Lancet. 2025 Oct 10:S0140-6736(25)01920-8. doi: 10.1016/S0140-6736(25)01920.
    >> Share

    September 2025
  11. VAN DER WINDT LI, Oudijk MA
    Atosiban for threatened preterm birth: the APOSTEL 8 trial - Authors' reply.
    Lancet. 2025;406:1339-1340.
    >> Share

  12. ZEGARRA RR, Valentini B, Ghi T
    Atosiban for threatened preterm birth: the APOSTEL 8 trial.
    Lancet. 2025;406:1339.
    >> Share

  13. LOUSSERT L, Garabedian C, Dupuis N, Bujold E, et al
    Atosiban for threatened preterm birth: the APOSTEL 8 trial.
    Lancet. 2025;406:1338-1339.
    >> Share

    August 2025
  14. IRFAN B, Abuhaiba S, Abusultan M, Nassar O, et al
    Is Gaza still a place for newborn life?
    Lancet. 2025;406:803.
    >> Share

    July 2025
  15. CLARK H, Khosla R
    The Partnership for Maternal, Newborn, and Child Health: 2026-30 strategy.
    Lancet. 2025 Jul 24:S0140-6736(25)01519-3. doi: 10.1016/S0140-6736(25)01519.
    >> Share

  16. DUGDALE CM, Ufio O, Giardina J, Shebl F, et al
    Estimating the effect of maternal viral load on perinatal and postnatal HIV transmission: a systematic review and meta-analysis.
    Lancet. 2025 Jul 10:S0140-6736(25)00765-2. doi: 10.1016/S0140-6736(25)00765.
    >> Share

    June 2025
  17. FERNANDEZ TURIENZO C, November L, Kamara M, Conteh O, et al
    Community-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial.
    Lancet. 2025 Jun 18:S0140-6736(25)00454-4. doi: 10.1016/S0140-6736(25)00454.
    >> Share

  18. HODNETT E
    A community-based landmark trial to save the lives of pregnant adolescents and their newborns in sub-Saharan Africa.
    Lancet. 2025 Jun 18:S0140-6736(25)00731-7. doi: 10.1016/S0140-6736(25)00731.
    >> Share

    May 2025
  19. YANG XY, Zhang GJ, Zhou YB
    Positive RPR and TPLA tests cannot confirm congenital syphilis.
    Lancet. 2025;405:1663.
    >> Share

  20. HIRATE T, Shinoda K, Tetsuka N
    Positive RPR and TPLA tests cannot confirm congenital syphilis - Authors' reply.
    Lancet. 2025;405:1663-1664.
    >> Share

    April 2025
  21. SY I, Sarr SC, Doucoure A
    Strengthening health systems and accountability: Senegal's path to success in reproductive, maternal, newborn, and child health.
    Lancet. 2025 Apr 9:S0140-6736(25)00616-6. doi: 10.1016/S0140-6736(25)00616.
    >> Share

    March 2025
  22. MAKAMA M, Vogel JP
    Atosiban and managing women in preterm labour.
    Lancet. 2025 Mar 3:S0140-6736(25)00402-7. doi: 10.1016/S0140-6736(25)00402.
    >> Share

  23. VAN DER WINDT LI, Klumper J, Duijnhoven RG, Kok M, et al
    Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial.
    Lancet. 2025 Mar 3:S0140-6736(25)00295-8. doi: 10.1016/S0140-6736(25)00295.
    >> Share

    February 2025
  24. CIDECIYAN AV, Aleman TS
    Gene therapy for young children with congenital blindness.
    Lancet. 2025;405:601-603.
    >> Share

    November 2024
  25. NORHEIM OF, Chang AY, Bolongaita S, Barraza-Llorens M, et al
    Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions.
    Lancet. 2024 Nov 20:S0140-6736(24)02417-6. doi: 10.1016/S0140-6736(24)02417.
    >> Share

  26. BLENCOWE H, Hug L
    Counting every newborn: liveborn or stillborn.
    Lancet. 2024 Nov 4:S0140-6736(24)02250-5. doi: 10.1016/S0140-6736(24)02250.
    >> Share

  27. IRFAN B, Abu Shammala A, Saleh K
    Will there be a future for newborns in Gaza?
    Lancet. 2024;404:1725-1726.
    >> Share

    October 2024
  28. JAMISON DT, Summers LH, Chang AY, Karlsson O, et al
    Global health 2050: the path to halving premature death by mid-century.
    Lancet. 2024;404:1561-1614.
    >> Share

    September 2024
  29. IMANI-MUSIMWA P, Ververs M
    Mpox and breastmilk: for once, can we act in time?
    Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
    >> Share

  30. HIRATE T, Kanda K, Ohshima Y, Shinoda K, et al
    Congenital syphilis in a 2-month-old infant during Japanese outbreak.
    Lancet. 2024;404:971.
    >> Share

  31. YANG P, Pardon LP, Ho AC, Lauer AK, et al
    Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study.
    Lancet. 2024;404:962-970.
    >> Share

  32. SINGH T, Kumar D
    Perinatal risk in India's Scheduled Tribes.
    Lancet. 2024;404:933-934.
    >> Share

    July 2024
  33. BERKLEY JA, Walson JL, Bahl R, Rollins N, et al
    Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact.
    Lancet. 2024 Jul 25:S0140-6736(24)00750-5. doi: 10.1016/S0140-6736(24)00750.
    >> Share

  34. SERMET-GAUDELUS I, Benaboud S, Bui S, Bihouee T, et al
    Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis.
    Lancet. 2024;404:117-120.
    >> Share

  35. SAMARASEKERA U
    Nahya Salim Masoud: improving newborn health in Tanzania.
    Lancet. 2024;404:19.
    >> Share

    June 2024
  36. STRUNK T, Molloy EJ, Mishra A, Bhutta ZA, et al
    Neonatal bacterial sepsis.
    Lancet. 2024 Jun 26:S0140-6736(24)00495-1. doi: 10.1016/S0140-6736(24)00495.
    >> Share

  37. DEVI S
    Challenges for infant schistosomiasis treatment.
    Lancet. 2024;403:2682.
    >> Share

  38. BEATTIE A, Moore A, Ramagopalan SV
    Genericisation in cost-effectiveness analysis of cystic fibrosis medicines.
    Lancet. 2024;403:2591-2592.
    >> Share

    May 2024
  39. TUMUKUNDE V, Medvedev MM, Tann CJ, Mambule I, et al
    Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.
    Lancet. 2024 May 13:S0140-6736(24)00064-3. doi: 10.1016/S0140-6736(24)00064.
    >> Share

    March 2024
  40. DADOUN S, Demmler-Harrison GJ, Ketwaroo P, Castro EC, et al
    Congenital toxoplasmosis of the brain caused by infection in late pregnancy.
    Lancet. 2024;403:1081-1082.
    >> Share

  41. EWER AK, Edi-Osagie N, Adams E
    Newborn pulse oximetry screening: time for equity in the UK?
    Lancet. 2024 Mar 11:S0140-6736(24)00417-3. doi: 10.1016/S0140-6736(24)00417.
    >> Share

    February 2024
  42. OKWARAJI YB, Krasevec J, Bradley E, Conkle J, et al
    National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysis.
    Lancet. 2024 Feb 28:S0140-6736(23)01198-4. doi: 10.1016/S0140-6736(23)01198.
    >> Share

  43. YANG Z, Chang S
    Accelerating the progress of low birthweight reduction.
    Lancet. 2024 Feb 28:S0140-6736(23)01669-0. doi: 10.1016/S0140-6736(23)01669.
    >> Share

  44. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
    The INSPIRE study: RSV infection during infancy - Authors' reply.
    Lancet. 2024;403:729-730.
    >> Share

  45. HSU NC, Hsu CH
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:729.
    >> Share

  46. TAO L, Liu J
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:728-729.
    >> Share

  47. OCHOGE M, Futa AC, Umesi A, Affleck L, et al
    Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
    Lancet. 2024 Feb 22:S0140-6736(23)02844-1. doi: 10.1016/S0140-6736(23)02844.
    >> Share

    October 2023
  48. COUSINS S
    Expanding access to breastmilk banks.
    Lancet. 2023;402:1514-1515.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016